POLATUZUMAB VEDOTIN

POLATUZUMAB VEDOTIN was reported 10202 times

POLATUZUMAB VEDOTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADENOVIRAL ENCEPHALITIS 4 0.3636
1 ORTHOSTATIC HEADACHE 4 0.2500
2 LEUKAEMIC LYMPHOMA 7 0.1842
3 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 391 0.1772
4 KIDNEY MALROTATION 6 0.1463
5 FOLLICULAR LYMPHOMA RECURRENT 11 0.1375
6 URETERIC COMPRESSION 10 0.1316
7 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 114 0.1204
8 LYMPHOMA TRANSFORMATION 40 0.1111
9 CORYNEBACTERIUM SEPSIS 6 0.0909
10 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT 4 0.0870
11 REFRACTORY CANCER 17 0.0794
12 OVARIAN NECROSIS 5 0.0794
13 PERITONEAL CARCINOMA METASTATIC 5 0.0794
14 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 26 0.0793
15 GASTROENTERITIS ASTROVIRAL 6 0.0750
16 MYOFASCITIS 6 0.0723
17 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA 8 0.0684
18 CYSTITIS VIRAL 24 0.0627
19 HYPOGLOSSAL NERVE PARALYSIS 4 0.0625
20 TRANSURETHRAL BLADDER RESECTION 5 0.0610
21 ABDOMINAL INCARCERATED HERNIA 3 0.0600
22 DIFFUSE LARGE B-CELL LYMPHOMA 428 0.0555
23 FOLLICULAR LYMPHOMA 45 0.0511
24 BACTEROIDES BACTERAEMIA 3 0.0500
25 CANDIDA PNEUMONIA 16 0.0495
26 MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL 6 0.0492
27 TUMOUR OBSTRUCTION 4 0.0460
28 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 4 0.0449
29 HYPOGLOBULINAEMIA 5 0.0442
30 ILIUM FRACTURE 9 0.0439
31 RETROPERITONEAL MASS 6 0.0435
32 LUNG ADENOCARCINOMA STAGE I 3 0.0417
33 HUMAN POLYOMAVIRUS INFECTION 22 0.0414
34 RETROPERITONEAL LYMPHADENOPATHY 20 0.0380
35 GRANULOMATOUS LYMPHADENITIS 7 0.0374
36 VIRAL VASCULITIS 4 0.0374
37 BLOOD CHOLINESTERASE DECREASED 10 0.0365
38 B-CELL LYMPHOMA REFRACTORY 3 0.0337
39 HYDROURETER 12 0.0316
40 NECROTISING SOFT TISSUE INFECTION 7 0.0303
41 CYTOMEGALOVIRUS INFECTION REACTIVATION 133 0.0301
42 CORONAVIRUS PNEUMONIA 5 0.0299
43 FUNGAL DISEASE CARRIER 3 0.0297
44 PERIPHERAL VEIN THROMBOSIS 7 0.0293
45 CATHETER SITE THROMBOSIS 8 0.0292
46 BLOOD IMMUNOGLOBULIN M ABNORMAL 3 0.0291
47 NODULAR MELANOMA 5 0.0289
48 CYTOMEGALOVIRUS ENTEROCOLITIS 22 0.0286
49 BILE ACIDS INCREASED 5 0.0282
50 GENITOURINARY SYMPTOM 5 0.0275
51 CYTOKINE RELEASE SYNDROME 542 0.0270
52 LIMB FRACTURE 4 0.0267
53 BLOOD LACTATE DEHYDROGENASE INCREASED 419 0.0264
54 CENTRAL NERVOUS SYSTEM NECROSIS 7 0.0255
55 TUMOUR ULCERATION 6 0.0253
56 TOXOPLASMOSIS 27 0.0250
57 LYMPHOMA 383 0.0248
58 CUTANEOUS LYMPHOMA 5 0.0245
59 PNEUMONIA ESCHERICHIA 8 0.0235
60 INGUINAL MASS 6 0.0235
61 TRI-IODOTHYRONINE FREE DECREASED 6 0.0235
62 BONE MARROW INFILTRATION 9 0.0233
63 METASTATIC LYMPHOMA 9 0.0230
64 CYTOKINE INCREASED 3 0.0222
65 NEURALGIC AMYOTROPHY 5 0.0221
66 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 127 0.0214
67 HIGH-GRADE B-CELL LYMPHOMA 4 0.0214
68 ABDOMINAL LYMPHADENOPATHY 18 0.0207
69 MORGANELLA INFECTION 6 0.0205
70 BLOOD BILIRUBIN DECREASED 12 0.0194
71 SARCOID-LIKE REACTION 5 0.0194
72 TUMOUR FLARE 13 0.0190
73 PROCALCITONIN INCREASED 22 0.0187
74 BODY TEMPERATURE 5 0.0187
75 CENTRAL NERVOUS SYSTEM NEOPLASM 3 0.0186
76 CYTOMEGALOVIRUS GASTROENTERITIS 4 0.0185
77 CYTOMEGALOVIRUS TEST POSITIVE 33 0.0185
78 BLOOD LACTATE DEHYDROGENASE DECREASED 6 0.0180
79 BLOOD IMMUNOGLOBULIN G ABNORMAL 3 0.0180
80 NEUTROPENIC INFECTION 17 0.0178
81 SOFT TISSUE INFLAMMATION 6 0.0178
82 DISEASE PROGRESSION 2064 0.0174
83 HYPOGAMMAGLOBULINAEMIA 113 0.0172
84 C-REACTIVE PROTEIN DECREASED 11 0.0168
85 BONE METABOLISM DISORDER 5 0.0166
86 CARDIAC FAILURE HIGH OUTPUT 4 0.0166
87 HUMORAL IMMUNE DEFECT 6 0.0162
88 HYPOPROTEINAEMIA 30 0.0158
89 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 3 0.0154
90 GASTROINTESTINAL LYMPHOMA 4 0.0154
91 CYTOPENIA 187 0.0153
92 PSEUDOMONAL BACTERAEMIA 13 0.0152
93 TUMOUR INVASION 7 0.0144
94 CYTOMEGALOVIRUS HEPATITIS 5 0.0141
95 CYTOMEGALOVIRUS ENTERITIS 5 0.0140
96 HYPERCREATININAEMIA 7 0.0139
97 ALANINE AMINOTRANSFERASE DECREASED 10 0.0138
98 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 5 0.0137
99 MALIGNANT PERITONEAL NEOPLASM 8 0.0135
100 HYPERURICAEMIA 55 0.0134
101 ASPARTATE AMINOTRANSFERASE DECREASED 7 0.0132
102 MUCOSAL INFECTION 3 0.0128
103 LYMPHOCYTE COUNT DECREASED 221 0.0125
104 PNEUMONIA PSEUDOMONAL 19 0.0124
105 MECHANICAL ILEUS 7 0.0123
106 SMALL INTESTINAL PERFORATION 23 0.0123
107 RESORPTION BONE INCREASED 10 0.0122
108 OTOTOXICITY 22 0.0119
109 GRANULOCYTE COUNT DECREASED 22 0.0119
110 B-CELL APLASIA 3 0.0116
111 POSITRON EMISSION TOMOGRAM ABNORMAL 8 0.0114
112 ENTEROCOCCAL BACTERAEMIA 12 0.0113
113 BLADDER HYPERTROPHY 5 0.0113
114 ABDOMINAL NEOPLASM 10 0.0112
115 CANDIDA SEPSIS 10 0.0111
116 MALIGNANT TRANSFORMATION 5 0.0111
117 TUMOUR LYSIS SYNDROME 98 0.0111
118 HYPOFIBRINOGENAEMIA 11 0.0111
119 VARICELLA ZOSTER VIRUS INFECTION 23 0.0111
120 HYPOALBUMINAEMIA 86 0.0110
121 B-CELL LYMPHOMA RECURRENT 6 0.0110
122 BACTERIAL DISEASE CARRIER 8 0.0110
123 INTERLEUKIN LEVEL INCREASED 6 0.0109
124 OPPORTUNISTIC INFECTION 20 0.0108
125 KLEBSIELLA TEST POSITIVE 7 0.0108
126 PNEUMOCOCCAL SEPSIS 7 0.0107
127 KLEBSIELLA SEPSIS 12 0.0106
128 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 13 0.0104
129 NEUTROPHIL COUNT DECREASED 421 0.0103
130 HEPATITIS B SURFACE ANTIBODY POSITIVE 3 0.0103
131 HYPOCHLORAEMIA 12 0.0102
132 HILAR LYMPHADENOPATHY 9 0.0102
133 PELVIC VENOUS THROMBOSIS 14 0.0098
134 PROTEUS INFECTION 7 0.0097
135 CHYLOTHORAX 7 0.0097
136 GASTROINTESTINAL FUNGAL INFECTION 5 0.0097
137 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 3 0.0096
138 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 4 0.0095
139 CHRONIC HEPATITIS B 3 0.0095
140 EPIDIDYMITIS 11 0.0095
141 FEBRILE INFECTION 11 0.0093
142 HAEMATOTOXICITY 88 0.0093
143 SARCOPENIA 4 0.0092
144 DYSPLASIA 11 0.0092
145 ENCEPHALITIS CYTOMEGALOVIRUS 4 0.0091
146 CYTOMEGALOVIRUS INFECTION 148 0.0089
147 DIARRHOEA INFECTIOUS 7 0.0089
148 FAECAL OCCULT BLOOD POSITIVE 3 0.0085
149 GASTROINTESTINAL OBSTRUCTION 20 0.0083
150 FEBRILE NEUTROPENIA 549 0.0083
151 MYELOSUPPRESSION 296 0.0082
152 ADENOMA BENIGN 7 0.0081
153 ORAL FUNGAL INFECTION 22 0.0080
154 MYOCARDIAL INJURY 9 0.0080
155 CENTRAL NERVOUS SYSTEM LYMPHOMA 11 0.0080
156 HEPATITIS B CORE ANTIBODY POSITIVE 3 0.0080
157 METASTASES TO MENINGES 18 0.0079
158 SUBCLAVIAN VEIN THROMBOSIS 9 0.0079
159 HYPOMETABOLISM 3 0.0079
160 BILIARY OBSTRUCTION 10 0.0077
161 ASYMPTOMATIC COVID-19 3 0.0076
162 SUPERINFECTION BACTERIAL 6 0.0076
163 PERIPHERAL SENSORY NEUROPATHY 44 0.0075
164 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 16 0.0075
165 HEPATITIS B 45 0.0075
166 PELVIC MASS 6 0.0074
167 BLOOD URIC ACID ABNORMAL 3 0.0074
168 POST-ACUTE COVID-19 SYNDROME 9 0.0073
169 GLOMERULAR FILTRATION RATE INCREASED 6 0.0073
170 PERIPHERAL MOTOR NEUROPATHY 10 0.0071
171 BACTERIURIA 4 0.0071
172 VIRAL HAEMORRHAGIC CYSTITIS 5 0.0070
173 HEPATITIS B REACTIVATION 22 0.0069
174 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 56 0.0068
175 CAMPYLOBACTER GASTROENTERITIS 4 0.0067
176 ATRIAL TACHYCARDIA 14 0.0067
177 SUPERIOR VENA CAVA SYNDROME 4 0.0066
178 DISSEMINATED CRYPTOCOCCOSIS 5 0.0066
179 CLOSTRIDIUM COLITIS 8 0.0066
180 PARAINFLUENZAE VIRUS INFECTION 10 0.0066
181 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 18 0.0065
182 CEREBRAL ASPERGILLOSIS 4 0.0065
183 CORONAVIRUS INFECTION 43 0.0065
184 BACTERIAL SEPSIS 21 0.0064
185 SYSTEMIC CANDIDA 16 0.0064
186 COVID-19 PNEUMONIA 75 0.0063
187 URINARY HESITATION 15 0.0063
188 LYMPHADENOPATHY MEDIASTINAL 12 0.0063
189 GASTROINTESTINAL PERFORATION 26 0.0062
190 NEUTROPENIC SEPSIS 44 0.0062
191 CYTOMEGALOVIRUS CHORIORETINITIS 12 0.0061
192 HYPERMAGNESAEMIA 4 0.0061
193 ENDOCARDITIS STAPHYLOCOCCAL 3 0.0061
194 LUNG OPACITY 16 0.0061
195 CAMPYLOBACTER INFECTION 5 0.0060
196 JC POLYOMAVIRUS TEST POSITIVE 7 0.0060
197 BACTERAEMIA 71 0.0060
198 ACUTE LEFT VENTRICULAR FAILURE 4 0.0060
199 HEAT ILLNESS 4 0.0059
200 BLOOD LACTATE DEHYDROGENASE ABNORMAL 4 0.0059
201 PNEUMONIA INFLUENZAL 7 0.0059
202 CYTOMEGALOVIRUS VIRAEMIA 26 0.0058
203 AORTIC VALVE CALCIFICATION 3 0.0058
204 MENINGITIS CRYPTOCOCCAL 10 0.0057
205 FUSARIUM INFECTION 4 0.0057
206 HYPERMETABOLISM 3 0.0057
207 JC VIRUS INFECTION 9 0.0056
208 CD4 LYMPHOCYTES DECREASED 12 0.0056
209 HYPERPHOSPHATAEMIA 12 0.0056
210 HYPOPHOSPHATAEMIA 41 0.0055
211 VASCULAR DEVICE INFECTION 25 0.0055
212 NEOPLASM 63 0.0055
213 POLYNEUROPATHY 64 0.0053
214 B-CELL LYMPHOMA 18 0.0053
215 CYSTITIS HAEMORRHAGIC 21 0.0052
216 LYMPHOCYTE MORPHOLOGY ABNORMAL 3 0.0052
217 ENTEROCOCCAL INFECTION 25 0.0052
218 BLOOD CREATININE DECREASED 16 0.0051
219 ESCHERICHIA BACTERAEMIA 12 0.0051
220 UROSEPSIS 47 0.0051
221 DEVICE RELATED THROMBOSIS 5 0.0051
222 BLOOD FIBRINOGEN INCREASED 4 0.0051
223 CRYSTAL NEPHROPATHY 3 0.0051
224 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 38 0.0051
225 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 3 0.0050
226 BONE MARROW DISORDER 15 0.0050
227 BRONCHOPULMONARY ASPERGILLOSIS 38 0.0049
228 OSTEOLYSIS 10 0.0049
229 CORONAVIRUS TEST POSITIVE 5 0.0049
230 BILIARY TRACT INFECTION 3 0.0048
231 HEPATOBILIARY DISEASE 3 0.0048
232 PNEUMOCYSTIS JIROVECII PNEUMONIA 48 0.0048
233 PERIPHERAL SENSORIMOTOR NEUROPATHY 6 0.0048
234 INFECTED SKIN ULCER 9 0.0048
235 SUPERFICIAL VEIN THROMBOSIS 4 0.0048
236 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 4 0.0047
237 NEUTROPENIA 642 0.0047
238 HYDRONEPHROSIS 35 0.0047
239 BLOOD IMMUNOGLOBULIN A DECREASED 3 0.0046
240 ANISOCYTOSIS 3 0.0046
241 TUMOUR PSEUDOPROGRESSION 5 0.0046
242 CARDIAC DYSFUNCTION 17 0.0046
243 PERIPHERAL NERVE INJURY 4 0.0046
244 HYPERLEUKOCYTOSIS 4 0.0045
245 ESCHERICHIA URINARY TRACT INFECTION 19 0.0045
246 MONOCYTE COUNT INCREASED 16 0.0044
247 HYPOCALCAEMIA 83 0.0044
248 ARTERIAL HAEMORRHAGE 5 0.0044
249 IMMUNOGLOBULINS DECREASED 6 0.0044
250 ORAL PRURITUS 10 0.0044
251 RADIATION SKIN INJURY 5 0.0043
252 THERAPY PARTIAL RESPONDER 66 0.0042
253 BLOOD ALKALINE PHOSPHATASE DECREASED 4 0.0042
254 MYELOPATHY 8 0.0042
255 ERYSIPELAS 21 0.0042
256 AGRANULOCYTOSIS 77 0.0041
257 GASTROINTESTINAL SCARRING 3 0.0041
258 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 21 0.0041
259 HEPATIC CYST 14 0.0041
260 PNEUMONIA CYTOMEGALOVIRAL 8 0.0041
261 PLATELET COUNT DECREASED 434 0.0041
262 LYMPHADENOPATHY 143 0.0040
263 ORGANISING PNEUMONIA 20 0.0040
264 AZOTAEMIA 16 0.0040
265 BLOOD IMMUNOGLOBULIN M DECREASED 4 0.0040
266 AGE-RELATED MACULAR DEGENERATION 6 0.0039
267 HYPOMAGNESAEMIA 55 0.0039
268 JUGULAR VEIN THROMBOSIS 7 0.0039
269 SHOCK HAEMORRHAGIC 32 0.0039
270 PNEUMONIA BACTERIAL 36 0.0039
271 ESCHERICHIA INFECTION 32 0.0039
272 NECK MASS 11 0.0039
273 NEUTROPENIC COLITIS 8 0.0039
274 ADJUSTMENT DISORDER 5 0.0038
275 NEUROPATHY PERIPHERAL 364 0.0038
276 FUNGAEMIA 6 0.0038
277 OSTEOSCLEROSIS 6 0.0038
278 WHITE BLOOD CELL COUNT DECREASED 412 0.0038
279 TUMOUR PAIN 5 0.0038
280 PNEUMOPERITONEUM 7 0.0038
281 HYPERPYREXIA 16 0.0038
282 NEOPLASM PROGRESSION 130 0.0037
283 THROMBOCYTOPENIA 417 0.0037
284 HYPOKALAEMIA 172 0.0037
285 LYMPHOCYTOSIS 8 0.0037
286 ILEUS 46 0.0037
287 URETERIC OBSTRUCTION 5 0.0037
288 LUNG ADENOCARCINOMA 11 0.0037
289 SEPTIC SHOCK 159 0.0037
290 BALANOPOSTHITIS 3 0.0036
291 ENTEROCOLITIS 21 0.0036
292 RED CELL DISTRIBUTION WIDTH INCREASED 15 0.0036
293 CHRONIC GRAFT VERSUS HOST DISEASE 13 0.0036
294 METASTASES TO PERITONEUM 9 0.0036
295 NEOPLASM RECURRENCE 12 0.0035
296 CHOROIDAL NEOVASCULARISATION 3 0.0035
297 LEUKOPENIA 175 0.0035
298 AXONAL NEUROPATHY 3 0.0034
299 PULMONARY SEPSIS 5 0.0034
300 ABDOMINAL SEPSIS 3 0.0034
301 IMMUNOSUPPRESSION 30 0.0034
302 URINARY TRACT OBSTRUCTION 8 0.0034
303 INTERCEPTED PRODUCT STORAGE ERROR 12 0.0034
304 ABDOMINAL MASS 9 0.0034
305 ATYPICAL PNEUMONIA 10 0.0033
306 BLOOD HIV RNA INCREASED 6 0.0033
307 LYMPHADENITIS 8 0.0033
308 SECONDARY IMMUNODEFICIENCY 4 0.0033
309 ASPARTATE AMINOTRANSFERASE INCREASED 175 0.0033
310 OESOPHAGEAL CANDIDIASIS 13 0.0033
311 AMYLASE INCREASED 12 0.0032
312 PANCREATIC NEOPLASM 4 0.0032
313 MYELITIS 5 0.0032
314 BLOOD IMMUNOGLOBULIN G DECREASED 8 0.0032
315 PROTEIN TOTAL DECREASED 12 0.0032
316 PANCYTOPENIA 177 0.0032
317 KLEBSIELLA BACTERAEMIA 3 0.0032
318 GAMMA-GLUTAMYLTRANSFERASE INCREASED 70 0.0032
319 OSTEOPOROTIC FRACTURE 6 0.0031
320 COVID-19 549 0.0031
321 GASTROINTESTINAL TOXICITY 15 0.0031
322 ESCHERICHIA SEPSIS 9 0.0031
323 LIVER ABSCESS 10 0.0031
324 NEUROTOXICITY 54 0.0031
325 LYMPHOPROLIFERATIVE DISORDER 9 0.0031
326 GRAFT VERSUS HOST DISEASE 22 0.0031
327 VENOUS THROMBOSIS 12 0.0031
328 C-REACTIVE PROTEIN INCREASED 111 0.0030
329 CYTOMEGALOVIRUS COLITIS 7 0.0030
330 ANAEMIA 577 0.0030
331 CLOSTRIDIUM DIFFICILE COLITIS 32 0.0030
332 MUCOSAL INFLAMMATION 79 0.0030
333 MALIGNANT NEOPLASM PROGRESSION 309 0.0030
334 ACQUIRED HAEMOPHILIA 3 0.0030
335 TONGUE DRY 4 0.0029
336 BLADDER NEOPLASM 5 0.0029
337 BONE MARROW OEDEMA 3 0.0029
338 LIVEDO RETICULARIS 6 0.0029
339 BLOOD DISORDER 23 0.0029
340 CARDIOMYOPATHY 42 0.0028
341 HYPERCALCAEMIA 35 0.0028
342 RENAL NEOPLASM 6 0.0028
343 RHINOVIRUS INFECTION 11 0.0028
344 ENTERITIS 18 0.0028
345 DUODENAL ULCER HAEMORRHAGE 8 0.0028
346 BACTERIAL INFECTION 52 0.0028
347 SECOND PRIMARY MALIGNANCY 23 0.0028
348 LYMPHOPENIA 39 0.0028
349 ASPERGILLUS INFECTION 18 0.0027
350 ACUTE ABDOMEN 4 0.0027
351 MASS 38 0.0027
352 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 3 0.0027
353 PNEUMONITIS 73 0.0027
354 NEUROLOGICAL SYMPTOM 15 0.0026
355 INFLAMMATORY MARKER INCREASED 13 0.0026
356 DIFFUSE ALVEOLAR DAMAGE 3 0.0026
357 HERPES VIRUS INFECTION 15 0.0026
358 NEURITIS 4 0.0026
359 INTESTINAL PERFORATION 29 0.0026
360 THROMBOPHLEBITIS 9 0.0026
361 PNEUMONIA FUNGAL 10 0.0025
362 STAPHYLOCOCCAL BACTERAEMIA 11 0.0025
363 APPENDICECTOMY 9 0.0025
364 THERAPY NON-RESPONDER 112 0.0025
365 CARDIOTOXICITY 22 0.0025
366 MONOCYTE COUNT DECREASED 3 0.0025
367 ALANINE AMINOTRANSFERASE INCREASED 151 0.0025
368 CRYPTOCOCCOSIS 4 0.0025
369 CHOLANGITIS SCLEROSING 5 0.0024
370 RENAL MASS 5 0.0024
371 MALIGNANT PLEURAL EFFUSION 4 0.0024
372 SPLEEN DISORDER 4 0.0024
373 GLUCOSE URINE PRESENT 3 0.0024
374 LEFT VENTRICULAR FAILURE 8 0.0023
375 SEPSIS 258 0.0023
376 BLOOD BILIRUBIN INCREASED 62 0.0023
377 HERPES OPHTHALMIC 3 0.0023
378 DISEASE RECURRENCE 108 0.0023
379 GASTROENTERITIS NOROVIRUS 3 0.0023
380 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
381 LYMPHOCYTE PERCENTAGE DECREASED 3 0.0022
382 LARGE INTESTINAL HAEMORRHAGE 5 0.0022
383 OPHTHALMIC HERPES ZOSTER 4 0.0022
384 BLOOD ALKALINE PHOSPHATASE INCREASED 55 0.0022
385 MYELODYSPLASTIC SYNDROME 32 0.0022
386 MONOPARESIS 4 0.0022
387 LARGE INTESTINAL ULCER 6 0.0022
388 GASTRIC PERFORATION 6 0.0022
389 HEPATIC FUNCTION ABNORMAL 82 0.0022
390 ISCHAEMIC HEPATITIS 3 0.0022
391 RESPIRATORY TRACT INFECTION VIRAL 5 0.0021
392 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 5 0.0021
393 OTITIS MEDIA 7 0.0021
394 SARCOIDOSIS 10 0.0021
395 ILL-DEFINED DISORDER 127 0.0021
396 HEPATIC LESION 9 0.0021
397 BK VIRUS INFECTION 7 0.0021
398 SUPRAVENTRICULAR EXTRASYSTOLES 7 0.0021
399 GASTROINTESTINAL NECROSIS 6 0.0021
400 SPINAL CORD COMPRESSION 8 0.0021
401 EMBOLISM 17 0.0020
402 LEUKOCYTOSIS 37 0.0020
403 HAEMATOLOGICAL INFECTION 5 0.0020
404 HYPERAEMIA 4 0.0020
405 STAPHYLOCOCCAL SEPSIS 10 0.0020
406 NORMOCHROMIC NORMOCYTIC ANAEMIA 6 0.0020
407 PSEUDOMONAS INFECTION 17 0.0020
408 JAUNDICE CHOLESTATIC 7 0.0020
409 THROMBOPHLEBITIS SUPERFICIAL 6 0.0020
410 KLEBSIELLA INFECTION 10 0.0020
411 MULTIPLE ORGAN DYSFUNCTION SYNDROME 56 0.0020
412 CANCER PAIN 5 0.0020
413 INFECTION 283 0.0020
414 NEUTROPHIL COUNT INCREASED 20 0.0020
415 DIVERTICULAR PERFORATION 4 0.0019
416 VENOUS THROMBOSIS LIMB 4 0.0019
417 SUBILEUS 4 0.0019
418 LUNG ABSCESS 4 0.0019
419 TRANSAMINASES INCREASED 41 0.0018
420 BLOOD PHOSPHORUS INCREASED 5 0.0018
421 ELECTROLYTE IMBALANCE 21 0.0018
422 APHTHOUS ULCER 14 0.0018
423 SKIN MASS 12 0.0018
424 ACUTE MYELOID LEUKAEMIA 28 0.0018
425 SPLENOMEGALY 21 0.0018
426 CANDIDA INFECTION 30 0.0018
427 BLOOD LOSS ANAEMIA 4 0.0018
428 NERVOUS SYSTEM DISORDER 55 0.0018
429 LICHENOID KERATOSIS 4 0.0017
430 CREATININE RENAL CLEARANCE DECREASED 7 0.0017
431 METASTATIC MALIGNANT MELANOMA 4 0.0017
432 NEUROLOGICAL DECOMPENSATION 4 0.0017
433 ADENOVIRUS INFECTION 5 0.0017
434 AORTIC STENOSIS 6 0.0017
435 RESPIRATORY SYNCYTIAL VIRUS INFECTION 15 0.0017
436 PANCREATITIS CHRONIC 4 0.0017
437 DECREASED ACTIVITY 18 0.0017
438 MEAN CELL HAEMOGLOBIN DECREASED 3 0.0016
439 RENAL CELL CARCINOMA 8 0.0016
440 ACUTE RESPIRATORY FAILURE 31 0.0016
441 EJECTION FRACTION DECREASED 25 0.0016
442 PULMONARY FUNCTION TEST DECREASED 7 0.0016
443 OFF LABEL USE 1398 0.0016
444 URINARY TRACT INFECTION BACTERIAL 4 0.0016
445 PATHOLOGICAL FRACTURE 8 0.0016
446 POLYMYALGIA RHEUMATICA 5 0.0016
447 INTERSTITIAL LUNG DISEASE 76 0.0016
448 VENTRICULAR HYPOKINESIA 5 0.0016
449 AORTIC ARTERIOSCLEROSIS 4 0.0016
450 URINARY TRACT DISORDER 7 0.0016
451 METABOLIC DISORDER 9 0.0015
452 DEEP VEIN THROMBOSIS 100 0.0015
453 HEPATITIS TOXIC 4 0.0015
454 PYREXIA 531 0.0015
455 APLASIA 3 0.0015
456 MALNUTRITION 17 0.0015
457 ORAL CANDIDIASIS 20 0.0015
458 PEPTIC ULCER 5 0.0015
459 WHITE BLOOD CELL DISORDER 4 0.0015
460 CARDIAC FAILURE 120 0.0015
461 GLOMERULAR FILTRATION RATE DECREASED 18 0.0015
462 IMMUNE SYSTEM DISORDER 19 0.0014
463 THROMBOTIC MICROANGIOPATHY 14 0.0014
464 LUNG CONSOLIDATION 4 0.0014
465 PRODUCT LEAKAGE 8 0.0014
466 IMMUNODEFICIENCY 21 0.0014
467 HEPATITIS C 17 0.0014
468 HYPOTONIA 14 0.0014
469 METASTASES TO CENTRAL NERVOUS SYSTEM 18 0.0014
470 BLOOD ALBUMIN DECREASED 11 0.0014
471 BLOOD URIC ACID INCREASED 8 0.0014
472 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
473 GASTROENTERITIS 20 0.0014
474 FEMORAL NECK FRACTURE 7 0.0014
475 LIVER INJURY 33 0.0013
476 EMBOLISM VENOUS 4 0.0013
477 HAEMODYNAMIC INSTABILITY 10 0.0013
478 COMPRESSION FRACTURE 7 0.0013
479 ANAL FISSURE 7 0.0013
480 DUODENITIS 4 0.0013
481 PNEUMONIA 422 0.0013
482 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
483 HYPERTRANSAMINASAEMIA 9 0.0013
484 INFUSION SITE EXTRAVASATION 8 0.0013
485 EPSTEIN-BARR VIRUS INFECTION 8 0.0013
486 CHOLECYSTITIS 15 0.0013
487 RENAL CYST 10 0.0013
488 SUBDURAL HAEMATOMA 18 0.0013
489 BLOOD CREATININE INCREASED 82 0.0013
490 PNEUMONIA VIRAL 4 0.0013
491 LACUNAR INFARCTION 3 0.0013
492 HYPOVOLAEMIC SHOCK 6 0.0013
493 UPPER GASTROINTESTINAL HAEMORRHAGE 21 0.0012
494 GUILLAIN-BARRE SYNDROME 6 0.0012
495 GASTROINTESTINAL INFECTION 11 0.0012
496 HYPERKALAEMIA 43 0.0012
497 PRODUCT PREPARATION ISSUE 8 0.0012
498 SMALL INTESTINAL OBSTRUCTION 15 0.0012
499 HYPERTRIGLYCERIDAEMIA 7 0.0012
500 METASTASES TO LIVER 21 0.0012
501 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
502 CLOSTRIDIAL INFECTION 4 0.0012
503 TOOTH ABSCESS 12 0.0012
504 HEPATOSPLENOMEGALY 3 0.0012
505 CEREBRAL ISCHAEMIA 6 0.0012
506 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
507 INFUSION RELATED REACTION 77 0.0012
508 HAEMATOCRIT DECREASED 23 0.0012
509 HYPERBILIRUBINAEMIA 12 0.0012
510 PLATELET COUNT INCREASED 15 0.0011
511 FUNGAL INFECTION 38 0.0011
512 BLOOD LACTIC ACID INCREASED 6 0.0011
513 ANKYLOSING SPONDYLITIS 15 0.0011
514 SERUM FERRITIN INCREASED 6 0.0011
515 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
516 PULMONARY TOXICITY 8 0.0011
517 METASTASIS 8 0.0011
518 LIVER DISORDER 49 0.0011
519 BLOOD PHOSPHORUS DECREASED 4 0.0011
520 THROMBOCYTOSIS 4 0.0011
521 INTESTINAL ISCHAEMIA 6 0.0011
522 HIATUS HERNIA 14 0.0011
523 NECROSIS 6 0.0011
524 ABSCESS 17 0.0011
525 ACUTE LYMPHOCYTIC LEUKAEMIA 3 0.0011
526 FACIAL PARALYSIS 9 0.0011
527 NEUTROPHILIA 6 0.0011
528 HAEMATOLOGICAL MALIGNANCY 3 0.0011
529 GRANULOCYTOPENIA 6 0.0011
530 DRUG RESISTANCE 27 0.0011
531 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
532 TUMOUR MARKER INCREASED 5 0.0010
533 HYPOVOLAEMIA 6 0.0010
534 SPINAL PAIN 12 0.0010
535 STOMATITIS 62 0.0010
536 ASCITES 30 0.0010
537 ACUTE RESPIRATORY DISTRESS SYNDROME 18 0.0010
538 HYPERGLYCAEMIA 37 0.0010
539 HAEMOGLOBIN DECREASED 104 0.0010
540 TRICUSPID VALVE INCOMPETENCE 8 0.0010
541 GENERAL PHYSICAL HEALTH DETERIORATION 116 0.0010
542 VEIN DISORDER 5 0.0010
543 PRODUCT USE ISSUE 187 0.0010
544 SQUAMOUS CELL CARCINOMA OF SKIN 6 0.0010
545 SCAR 17 0.0010
546 ORGAN FAILURE 4 0.0010
547 RESPIRATORY FAILURE 72 0.0010
548 INGUINAL HERNIA 6 0.0010
549 PLEURAL EFFUSION 60 0.0010
550 INTESTINAL OBSTRUCTION 37 0.0010
551 SKIN INFECTION 11 0.0010
552 DYSAESTHESIA 3 0.0010
553 DEMYELINATION 4 0.0010
554 COLITIS 37 0.0010
555 REBOUND EFFECT 11 0.0010
556 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
557 HYPOXIA 34 0.0010
558 RESPIRATORY TRACT INFECTION 25 0.0010
559 SKIN LESION 26 0.0009
560 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
561 RED BLOOD CELL COUNT DECREASED 27 0.0009
562 LUNG NEOPLASM 4 0.0009
563 BONE MARROW FAILURE 19 0.0009
564 DEATH 801 0.0009
565 THERAPEUTIC RESPONSE DECREASED 56 0.0009
566 PYELONEPHRITIS 8 0.0009
567 DELIRIUM 32 0.0009
568 DIVERTICULUM INTESTINAL 4 0.0009
569 LIPASE INCREASED 7 0.0009
570 LISTLESS 3 0.0009
571 HAEMOLYSIS 7 0.0009
572 NO ADVERSE EVENT 164 0.0009
573 GASTRIC ULCER HAEMORRHAGE 5 0.0009
574 ILEUS PARALYTIC 4 0.0009
575 HEPATIC FAILURE 27 0.0009
576 ANGIOPATHY 5 0.0009
577 COLITIS ISCHAEMIC 6 0.0009
578 POSTOPERATIVE WOUND INFECTION 6 0.0009
579 ORAL HERPES 17 0.0009
580 HERPES ZOSTER 50 0.0009
581 ARRHYTHMIA 41 0.0009
582 LARGE INTESTINE PERFORATION 6 0.0009
583 PERFORMANCE STATUS DECREASED 4 0.0009
584 POLYURIA 7 0.0009
585 BRONCHIOLITIS 3 0.0009
586 PULMONARY EMBOLISM 81 0.0009
587 ATRIAL FIBRILLATION 83 0.0009
588 DUODENAL ULCER 6 0.0008
589 FIBRIN D DIMER INCREASED 3 0.0008
590 NODULE 11 0.0008
591 TASTE DISORDER 17 0.0008
592 NIGHT SWEATS 27 0.0008
593 BLOOD UREA INCREASED 14 0.0008
594 RENAL FAILURE 111 0.0008
595 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
596 BONE LESION 3 0.0008
597 HUMERUS FRACTURE 4 0.0008
598 ADRENAL INSUFFICIENCY 10 0.0008
599 CYSTITIS 26 0.0008
600 VIRAL INFECTION 27 0.0008
601 DERMATITIS 17 0.0008
602 BREATH SOUNDS ABNORMAL 4 0.0008
603 DIABETIC NEUROPATHY 4 0.0008
604 OLIGURIA 5 0.0008
605 ACUTE KIDNEY INJURY 123 0.0008
606 HYPERNATRAEMIA 4 0.0008
607 PROTEIN URINE PRESENT 4 0.0008
608 DRUG-INDUCED LIVER INJURY 25 0.0008
609 PAROSMIA 6 0.0008
610 MITRAL VALVE INCOMPETENCE 9 0.0008
611 TOXIC ENCEPHALOPATHY 4 0.0008
612 DECREASED APPETITE 183 0.0008
613 PRODUCT PREPARATION ERROR 16 0.0008
614 INTENTIONAL PRODUCT USE ISSUE 68 0.0008
615 SINUS TACHYCARDIA 11 0.0008
616 RENAL IMPAIRMENT 65 0.0008
617 HERPES SIMPLEX 5 0.0008
618 PULMONARY HAEMORRHAGE 6 0.0008
619 TENDON DISORDER 5 0.0008
620 POLYP 5 0.0008
621 HYPONATRAEMIA 43 0.0008
622 IRON DEFICIENCY ANAEMIA 7 0.0008
623 STAPHYLOCOCCAL INFECTION 25 0.0008
624 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
625 FLANK PAIN 7 0.0007
626 ACUTE MYOCARDIAL INFARCTION 22 0.0007
627 CEREBRAL INFARCTION 18 0.0007
628 DRUG ERUPTION 13 0.0007
629 ENCEPHALOPATHY 18 0.0007
630 METASTASES TO BONE 12 0.0007
631 INFARCTION 5 0.0007
632 EXTRAVASATION 3 0.0007
633 GASTROINTESTINAL HAEMORRHAGE 61 0.0007
634 LYMPHOEDEMA 5 0.0007
635 HEMIPLEGIA 6 0.0007
636 URINARY TRACT INFECTION 123 0.0007
637 COAGULOPATHY 12 0.0007
638 BONE PAIN 42 0.0007
639 HEPATOMEGALY 7 0.0007
640 PANCREATITIS ACUTE 16 0.0007
641 FISTULA 8 0.0007
642 EYE INFECTION 8 0.0007
643 STRESS CARDIOMYOPATHY 4 0.0007
644 CLOSTRIDIUM DIFFICILE INFECTION 15 0.0007
645 TEMPERATURE INTOLERANCE 7 0.0007
646 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
647 PERITONITIS 14 0.0007
648 HEPATOTOXICITY 15 0.0007
649 NEURALGIA 16 0.0007
650 TROPONIN INCREASED 5 0.0007
651 IMMUNE THROMBOCYTOPENIA 3 0.0007
652 LUMBAR VERTEBRAL FRACTURE 3 0.0007
653 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
654 PERICARDIAL EFFUSION 15 0.0006
655 LOCALISED OEDEMA 3 0.0006
656 INTERCEPTED MEDICATION ERROR 3 0.0006
657 CHOLANGITIS 4 0.0006
658 FULL BLOOD COUNT DECREASED 13 0.0006
659 NEPHROPATHY 6 0.0006
660 BLOOD SODIUM DECREASED 12 0.0006
661 CONSTIPATION 138 0.0006
662 GASTRIC ULCER 12 0.0006
663 PNEUMOTHORAX 10 0.0006
664 NERVE INJURY 7 0.0006
665 URINARY RETENTION 21 0.0006
666 HEPATIC CYTOLYSIS 8 0.0006
667 BLOOD CALCIUM DECREASED 7 0.0006
668 PRODUCT USE IN UNAPPROVED INDICATION 154 0.0006
669 MOUTH ULCERATION 13 0.0006
670 DIVERTICULITIS 17 0.0006
671 HICCUPS 5 0.0006
672 GASTRIC HAEMORRHAGE 7 0.0006
673 HYPERVOLAEMIA 3 0.0006
674 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
675 ABDOMINAL PAIN 140 0.0006
676 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
677 HYPOPHAGIA 15 0.0006
678 HYPERLIPIDAEMIA 7 0.0006
679 RASH MACULO-PAPULAR 13 0.0006
680 CACHEXIA 3 0.0006
681 ENCEPHALITIS 4 0.0006
682 DEAFNESS 15 0.0006
683 FULL BLOOD COUNT ABNORMAL 6 0.0006
684 SUDDEN DEATH 6 0.0006
685 LUNG INFILTRATION 5 0.0006
686 ULCER 9 0.0006
687 SCIATICA 9 0.0006
688 ANAL ABSCESS 3 0.0006
689 TONGUE DISORDER 4 0.0006
690 OPTIC NEURITIS 5 0.0005
691 DIARRHOEA 354 0.0005
692 VENTRICULAR TACHYCARDIA 9 0.0005
693 DUODENAL ULCER PERFORATION 4 0.0005
694 ERYTHEMA MULTIFORME 5 0.0005
695 COGNITIVE DISORDER 25 0.0005
696 APPENDICITIS 5 0.0005
697 LEUKAEMIA 5 0.0005
698 CHOLECYSTITIS ACUTE 3 0.0005
699 FRACTURE 10 0.0005
700 PROTEINURIA 10 0.0005
701 HAEMATURIA 18 0.0005
702 ATRIOVENTRICULAR BLOCK 4 0.0005
703 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
704 PULMONARY OEDEMA 23 0.0005
705 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
706 ISCHAEMIC STROKE 9 0.0005
707 MELAENA 11 0.0005
708 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
709 RENAL DISORDER 23 0.0005
710 EPILEPSY 15 0.0005
711 ASPHYXIA 4 0.0005
712 CARDIOGENIC SHOCK 7 0.0005
713 INTERCEPTED PRODUCT PREPARATION ERROR 6 0.0005
714 CONJUNCTIVITIS 9 0.0005
715 ABDOMINAL PAIN LOWER 12 0.0005
716 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 26 0.0005
717 PULMONARY MASS 7 0.0005
718 PULMONARY FIBROSIS 9 0.0005
719 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
720 BLOOD MAGNESIUM DECREASED 4 0.0005
721 TOXICITY TO VARIOUS AGENTS 78 0.0005
722 GASTROINTESTINAL DISORDER 41 0.0005
723 DEVICE RELATED INFECTION 7 0.0005
724 SARS-COV-2 TEST POSITIVE 6 0.0005
725 RESPIRATORY RATE INCREASED 4 0.0005
726 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
727 UVEITIS 6 0.0004
728 TACHYPNOEA 6 0.0004
729 ACUTE HEPATIC FAILURE 6 0.0004
730 RENAL INJURY 13 0.0004
731 WEIGHT DECREASED 122 0.0004
732 SENSORY DISTURBANCE 7 0.0004
733 CARDIAC ARREST 36 0.0004
734 EXTRASYSTOLES 3 0.0004
735 ASTHENIA 161 0.0004
736 DIVERTICULUM 3 0.0004
737 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
738 DERMATITIS BULLOUS 3 0.0004
739 SINUS BRADYCARDIA 4 0.0004
740 CARDIOMEGALY 5 0.0004
741 PHARYNGITIS 5 0.0004
742 ORTHOSTATIC HYPOTENSION 7 0.0004
743 DYSPHAGIA 38 0.0004
744 BLOOD POTASSIUM DECREASED 12 0.0004
745 CELLULITIS 20 0.0004
746 BODY TEMPERATURE INCREASED 8 0.0004
747 SHOCK 9 0.0004
748 CEREBRAL HAEMORRHAGE 14 0.0004
749 INFLAMMATION 20 0.0004
750 VENTRICULAR EXTRASYSTOLES 4 0.0004
751 DIPLOPIA 10 0.0004
752 PETECHIAE 4 0.0004
753 DRUG INEFFECTIVE 503 0.0004
754 DRY EYE 19 0.0004
755 HYPOTENSION 76 0.0004
756 RASH ERYTHEMATOUS 18 0.0004
757 ATRIAL FLUTTER 3 0.0004
758 PARAESTHESIA 59 0.0004
759 TACHYCARDIA 33 0.0004
760 FRUSTRATION TOLERANCE DECREASED 3 0.0004
761 OEDEMA 20 0.0004
762 OESOPHAGITIS 4 0.0004
763 ASPIRATION 4 0.0004
764 CHOLESTASIS 7 0.0004
765 MUSCLE INJURY 3 0.0004
766 PNEUMONIA ASPIRATION 9 0.0004
767 DEHYDRATION 48 0.0004
768 INFLUENZA 40 0.0004
769 NEPHROPATHY TOXIC 4 0.0004
770 BLINDNESS UNILATERAL 5 0.0004
771 HYPOAESTHESIA 53 0.0004
772 HAEMORRHAGE 37 0.0004
773 HEPATOCELLULAR INJURY 5 0.0004
774 BRONCHOSPASM 5 0.0004
775 MYOCARDITIS 4 0.0003
776 VASCULITIS 4 0.0003
777 EOSINOPHILIA 6 0.0003
778 GALLBLADDER DISORDER 6 0.0003
779 JAUNDICE 9 0.0003
780 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
781 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 23 0.0003
782 GENERALISED OEDEMA 4 0.0003
783 HEPATIC ENZYME INCREASED 22 0.0003
784 HAEMOPTYSIS 9 0.0003
785 HEPATIC STEATOSIS 6 0.0003
786 BASAL CELL CARCINOMA 5 0.0003
787 MENINGIOMA 5 0.0003
788 PRODUCT STORAGE ERROR 28 0.0003
789 CATARACT 19 0.0003
790 ARTERIOSCLEROSIS 3 0.0003
791 HAEMATEMESIS 8 0.0003
792 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
793 OEDEMA PERIPHERAL 38 0.0003
794 HAEMORRHOIDS 6 0.0003
795 LUNG DISORDER 15 0.0003
796 CHOLELITHIASIS 10 0.0003
797 PANCREATITIS 16 0.0003
798 DRUG INTOLERANCE 29 0.0003
799 MUSCULAR WEAKNESS 34 0.0003
800 AKATHISIA 4 0.0003
801 UNDERDOSE 21 0.0003
802 NEOPLASM MALIGNANT 19 0.0003
803 INCONTINENCE 3 0.0003
804 EATING DISORDER 6 0.0003
805 PARALYSIS 4 0.0003
806 SWELLING 26 0.0003
807 PROSTATE CANCER 22 0.0003
808 DYSURIA 10 0.0003
809 ABDOMINAL DISTENSION 28 0.0003
810 CONFUSIONAL STATE 43 0.0003
811 BLOOD COUNT ABNORMAL 4 0.0003
812 MYOCARDIAL ISCHAEMIA 3 0.0003
813 CARDIO-RESPIRATORY ARREST 11 0.0003
814 RECTAL HAEMORRHAGE 11 0.0003
815 COMA 12 0.0003
816 PRESCRIBED UNDERDOSE 5 0.0003
817 DEMENTIA 7 0.0003
818 NAUSEA 198 0.0002
819 DIABETES MELLITUS 19 0.0002
820 SPEECH DISORDER 13 0.0002
821 DYSPEPSIA 24 0.0002
822 TREATMENT FAILURE 20 0.0002
823 VOMITING 113 0.0002
824 DYSSTASIA 7 0.0002
825 TINNITUS 11 0.0002
826 CHILLS 28 0.0002
827 BRAIN OEDEMA 3 0.0002
828 HAEMATOCHEZIA 13 0.0002
829 CIRCULATORY COLLAPSE 4 0.0002
830 HEPATITIS 6 0.0002
831 LIVER FUNCTION TEST INCREASED 5 0.0002
832 GASTRITIS 6 0.0002
833 COUGH 63 0.0002
834 RASH PRURITIC 12 0.0002
835 PELVIC PAIN 4 0.0002
836 LACTIC ACIDOSIS 7 0.0002
837 FEELING COLD 6 0.0002
838 OXYGEN SATURATION DECREASED 12 0.0002
839 BLOOD URINE PRESENT 4 0.0002
840 BLOOD PRESSURE DECREASED 14 0.0002
841 DIABETIC KETOACIDOSIS 5 0.0002
842 FLUID OVERLOAD 3 0.0002
843 APATHY 3 0.0002
844 DYSPNOEA 115 0.0002
845 BRONCHITIS 15 0.0002
846 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
847 COLON CANCER 3 0.0002
848 HAEMORRHAGE INTRACRANIAL 3 0.0002
849 AGEUSIA 5 0.0002
850 SYNCOPE 20 0.0002
851 BACK PAIN 46 0.0002
852 FEEDING DISORDER 4 0.0002
853 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
854 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
855 SEIZURE 22 0.0002
856 INJECTION SITE REACTION 13 0.0002
857 CEREBROVASCULAR ACCIDENT 32 0.0002
858 PRODUCTIVE COUGH 9 0.0002
859 DISTURBANCE IN ATTENTION 10 0.0002
860 FAECES DISCOLOURED 4 0.0002
861 RASH 80 0.0002
862 FATIGUE 142 0.0002
863 VERTIGO 11 0.0002
864 FALL 60 0.0002
865 STEVENS-JOHNSON SYNDROME 4 0.0002
866 SKIN DISORDER 6 0.0002
867 NECK PAIN 10 0.0002
868 LIVER FUNCTION TEST ABNORMAL 5 0.0002
869 HYPERTENSION 36 0.0002
870 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
871 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
872 RESPIRATORY DISORDER 5 0.0002
873 MENTAL IMPAIRMENT 4 0.0002
874 MUSCLE SPASMS 30 0.0002
875 MALAISE 71 0.0002
876 THROMBOSIS 13 0.0002
877 FEMUR FRACTURE 5 0.0002
878 HEPATIC CIRRHOSIS 3 0.0002
879 MUSCULOSKELETAL DISORDER 3 0.0002
880 CARDIOVASCULAR DISORDER 4 0.0002
881 INCREASED APPETITE 3 0.0002
882 THERAPY CESSATION 8 0.0002
883 MOBILITY DECREASED 11 0.0002
884 BRADYCARDIA 8 0.0002
885 GAIT INABILITY 5 0.0001
886 DISCOMFORT 9 0.0001
887 ERYTHEMA 30 0.0001
888 CHRONIC KIDNEY DISEASE 11 0.0001
889 CONDITION AGGRAVATED 44 0.0001
890 MENTAL STATUS CHANGES 4 0.0001
891 POLLAKIURIA 6 0.0001
892 WOUND 4 0.0001
893 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
894 SINUSITIS 14 0.0001
895 LABORATORY TEST ABNORMAL 4 0.0001
896 HYPERHIDROSIS 17 0.0001
897 PERIPHERAL SWELLING 20 0.0001
898 CHEST DISCOMFORT 13 0.0001
899 OCULAR HYPERAEMIA 6 0.0001
900 HYPOTHYROIDISM 4 0.0001
901 HEPATIC CANCER 3 0.0001
902 HYPERSENSITIVITY 23 0.0001
903 PAIN 76 0.0001
904 ALOPECIA 24 0.0001
905 INFLUENZA LIKE ILLNESS 10 0.0001
906 VISUAL ACUITY REDUCED 4 0.0001
907 EPISTAXIS 9 0.0001
908 PALPITATIONS 14 0.0001
909 UNEVALUABLE EVENT 9 0.0001
910 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
911 ANAPHYLACTIC SHOCK 3 0.0001
912 HAEMATOMA 3 0.0001
913 MENTAL DISORDER 5 0.0001
914 LIMB INJURY 3 0.0001
915 RESTLESSNESS 4 0.0001
916 SOMNOLENCE 22 0.0001
917 DYSGEUSIA 8 0.0001
918 CARDIAC DISORDER 10 0.0001
919 DYSPNOEA EXERTIONAL 4 0.0001
920 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
921 OVERDOSE 22 0.0001
922 MEMORY IMPAIRMENT 14 0.0001
923 PAIN IN EXTREMITY 30 0.0001
924 DISORIENTATION 4 0.0001
925 CARDIAC FAILURE CONGESTIVE 8 0.0001
926 CORONARY ARTERY DISEASE 3 0.0001
927 BLINDNESS 4 0.0001
928 METABOLIC ACIDOSIS 3 0.0001
929 LOSS OF CONSCIOUSNESS 12 0.0001
930 SWELLING FACE 6 0.0001
931 HEART RATE INCREASED 9 0.0001
932 BLOOD GLUCOSE INCREASED 17 0.0001
933 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
934 LETHARGY 5 0.0001
935 DRY MOUTH 7 0.0001
936 BLOOD CHOLESTEROL INCREASED 4 0.0001
937 DYSPHONIA 5 0.0001
938 NASAL CONGESTION 5 0.0001
939 BLADDER CANCER 5 0.0001
940 PRURITUS 31 0.0001
941 MUSCULOSKELETAL PAIN 4 0.0001
942 ARTHRITIS 6 0.0001
943 HEADACHE 47 0.0001
944 DEPRESSION 17 0.0001
945 LUNG NEOPLASM MALIGNANT 3 0.0001
946 DIZZINESS 34 0.0001
947 GAIT DISTURBANCE 13 0.0001
948 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
949 HOT FLUSH 5 0.0001
950 NASOPHARYNGITIS 12 0.0001
951 CHEST PAIN 12 0.0001
952 DRUG INTERACTION 10 0.0001
953 MULTIPLE SCLEROSIS 3 0.0001
954 WEIGHT INCREASED 14 0.0001
955 RHINORRHOEA 4 0.0001
956 AMNESIA 4 0.0001
957 FLUID RETENTION 3 0.0001
958 INJURY 4 0.0001
959 DEPRESSED MOOD 3 0.0001
960 INSOMNIA 15 0.0001
961 ANAPHYLACTIC REACTION 3 0.0001
962 TREMOR 9 0.0001
963 OROPHARYNGEAL PAIN 5 0.0001
964 MEDICATION ERROR 3 0.0001
965 BLISTER 3 0.0001
966 VISION BLURRED 7 0.0001
967 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
968 URTICARIA 8 0.0000
969 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
970 ASTHMA 5 0.0000
971 ABDOMINAL PAIN UPPER 9 0.0000
972 ADVERSE EVENT 4 0.0000
973 ABDOMINAL DISCOMFORT 7 0.0000
974 CONTUSION 4 0.0000
975 MYALGIA 7 0.0000
976 AGITATION 3 0.0000
977 MYOCARDIAL INFARCTION 7 0.0000
978 HALLUCINATION 3 0.0000
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
980 FLUSHING 4 0.0000
981 FEELING ABNORMAL 9 0.0000
982 DRUG DEPENDENCE 6 0.0000
983 ANXIETY 9 0.0000
984 ILLNESS 3 0.0000
985 ARTHRALGIA 11 0.0000
986 BLOOD PRESSURE INCREASED 4 0.0000
987 PRODUCT DOSE OMISSION ISSUE 7 0.0000
988 DRY SKIN 3 0.0000
989 INCORRECT DOSE ADMINISTERED 4 0.0000